Want to see TSE:LOVE full AI Analyst Report?
Cannara Biotech (LOVE) Revenue
Cannara Biotech Revenue
Cannara Biotech had a revenue of 31.83M in the quarter ending May 31, 2026, with 17.10%. This bring the company's revenue in the last twelve months to 117.76M, Increased 3.97%. In the fiscal year ending Aug 31, 2025, Cannara Biotech had annual revenue of 107.32M with 31.28% growth.
- Revenue (ttm)
- 117.76M
- Revenue Growth
- 14.66%
- P/S Ratio
- 1.85
- Revenue/Employee
- CAD 237,426
- Employees
- 452
- Market Cap
- CAD 198.55M
Revenue Chart
Cannara Biotech Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 107.32M | 25.57M | 31.28% |
| Aug 31, 2024 | 81.75M | 24.49M | 42.77% |
| Nov 30, 2023 | 57.26M | 21.42M | 59.76% |
| Aug 31, 2022 | 35.84M | 18.82M | 110.58% |
| Nov 30, 2021 | 17.02M | 14.47M | 567.24% |
| Nov 30, 2020 | 2.55M | 453.88K | 21.64% |
| Aug 31, 2019 | 2.10M | 1.66M | 384.70% |
| Aug 31, 2018 | 432.64K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.